Adenosine Fresenius Kabi 3 mg/ml inj. sol. i.v. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

adenosine fresenius kabi 3 mg/ml inj. sol. i.v. pre-filled syr.

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

Adenosine Fresenius Kabi 3 mg/ml inj. sol. i.v. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

adenosine fresenius kabi 3 mg/ml inj. sol. i.v. pre-filled syr.

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

Adenosine Fresenius Kabi 3 mg/ml inj. sol. i.v. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

adenosine fresenius kabi 3 mg/ml inj. sol. i.v. pre-filled syr.

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

ADENOSINE 3 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 3 mg/ml solution for injection

fresenius kabi limited - adenosine - solution for injection - 3 mg/ml - other cardiac preparations

ADENOSINE- adenosine injection, solution United States - English - NLM (National Library of Medicine)

adenosine- adenosine injection, solution

heritage pharmaceuticals inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection, usp is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine injection is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [seewarnings and precautions (5.2) ] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine [seewarnings and precautions (5.7)] pregnancy category c. animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine injection can cause fetal harm when administered to pregnant women, adenosine injection should be used during pregnancy only if clea

Adenosine 3 mg/ml solution for injection in pre-filled syringe Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 3 mg/ml solution for injection in pre-filled syringe

fresenius kabi deutschland gmbh - adenosine - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - other cardiac preparations; adenosine

Adenosine 3mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

adenosine 3mg/ml solution for injection

wockhardt uk limited - adenosine - solution for injection - 3 milligram(s)/millilitre - other cardiac preparations; adenosine

Adenosine Solution for Injection 3mg/ml Malta - English - Medicines Authority

adenosine solution for injection 3mg/ml

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - adenosine - solution for injection - adenosine 3 mg - cardiac therapy

Adenohardt 3mg /ml Solution for Inj 3 mg/ml Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

adenohardt 3mg /ml solution for inj 3 mg/ml

مستودع أدوية الغروب - sun set drug store - adenosine 3 mg/ml - 3 mg/ml

Adenosine Baxter New Zealand - English - Medsafe (Medicines Safety Authority)

adenosine baxter

baxter healthcare ltd - adenosine 3 mg/ml;  ;   - solution for infusion - 30 mg/10ml - active: adenosine 3 mg/ml     excipient: sodium chloride water for injection - intravenous adenosine baxter 30 mg/10 ml is a coronary vasodilator for use in conjunction with radionuclide myocardial perfusion imaging, in patients unable to exercise adequately.